Published Online: 30 September 2026.
J. Biomed. Syst. Eng., 2026, 1(1), 26805 | Volume 1 Issue 1 (September 2026) | DOI: https://doi.org/10.64189/bse.26805
© The Author(s) 2026
This article is licensed under Creative Commons Attribution NonCommercial 4.0 International (CC-BY-NC 4.0)
Advancing Healthcare Technology: From Edge-AI
Diagnostics to Metagenomic Intelligence and
Biomaterial Sensors
Akash Kumar Bhoi
*
Department of Electronics and Telecommunication Engineering, Symbiosis Institute of Technology, Pune Campus, Symbiosis
International (Deemed University), Pune, Maharashtra, 412115, India
*Email: eic.jbse@gr-journals.com (Akash Kumar Bhoi)
The intrinsic convergence of computational intelligence, material science, and molecular biology underpins
modern healthcare engineering. At the nexus of this multidisciplinary interaction lies the urgent need for
scalable, real-time diagnostic tools that can operating seamlessly from the planetary scale of metagenomic
tracking to the micro-scale of wearable, edge-deployed physical sensors. Accelerating the translation of clinical
workflows requires bridging the gap between algorithmic models and physical engineering realities.
Addressing these complex healthcare demands necessitates robust software optimization frameworks, highly
sensitive biomaterial substrates, assistive accessibility pipelines, and reference-free deep learning models that
transcend classical alignment bottlenecks.
In response to these critical needs, we introduce the inaugural issue of the Journal of Biomedical Systems and
Engineering - a peer-reviewed, open-access forum dedicated to advancing research at the intersection of
medicine, hardware engineering, data science, and molecular diagnostics. Embracing the paradigm of
translational technology, the journal serves as a multidisciplinary platform for high-impact original research,
comprehensive reviews, and computational proof-of-concepts. Our inaugural issue features four contributions
that collectively span the continuum from individual edge-hardware optimization and localized point-of-care
biosensors to real-time assistive frameworks and deep-learning metagenomic architectures:
Odiba et al. provide a comprehensive review of the integration of Deep Learning (DL) with metagenomic
sequencing for advanced microbial species differentiation.
[1]
The authors evaluate four foundational neural
architecture families - convolutional, recurrent, transformer-based genomic language, and graph neural
networks - across clinical tasks including taxonomic classification, genome-resolved binning, and microbiome-
phenotype association.
[2,3]
The review contrasts these DL methodologies against conventional alignment-based
limitations, specifically highlighting hurdles such as data leakage, domain shift across platforms, and database
reference dependency. Ultimately, they outline the strategic necessity of reference-free, multi-modal
foundation models to achieve biologically robust microbial identification. Basak and Sahu execute a
comprehensive compression-aware ablation study aimed at continuous vital-sign anomaly detection on
wearable and bedside Internet of Medical Things (IoMT) hardware.
[4]
Utilizing a synthetic multi-variate vital-
sign dataset mapped against National Early Warning Score 2 (NEWS2) thresholds, the authors systematically
benchmark a baseline CNN-LSTM network against structured channel pruning, partial dynamic post-training
8-bit integer quantization, and knowledge distillation to a 1,662-parameter GRU student.
[5]
While the baseline
achieved an exceptional F1-score of 0.955, knowledge distillation yielded a massive 40.8-fold reduction in
multiply-accumulate operations while preserving a high F1-score of 0.912. Crucially, the authors separate their
software-sandbox metrics from a rigorous, self-contained implementation protocol designed to guide future
physical edge-hardware deployment and clinical verification. Shifting focus toward molecular-level real-time
monitoring, Kumar et al. present the numerical design and optimization of a highly sensitive, multilayer Surface
Plasmon Resonance (SPR) sensor for label-free urine glucose detection.
[6]
The architecture integrates a calcium
fluoride (CaF₂) prism coupled with a copper plasmonic layer, silicon dioxide (SiO₂), blue phosphorus (BlueP),
and a 2D Franckeite mineral heterostructure to maximize the interaction of the evanescent field with the
analyte.
[7,8]
The optimized configuration demonstrates an extraordinary maximum angular sensitivity of
385.55°/RIU and a peak Figure of Merit (FoM) of 82.31/RIU. This computational proof-of-concept establishes
a vital theoretical baseline for subsequent physical prototyping and clinical translation using real patient urine
samples. Moving from biochemical assays to human-computer interactions, Siddiqui et al. develop a real-time
assistive pipeline combining Indian Sign Language (ISL) alphabet recognition with temporal stabilization.
[9]
To